Revel Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Revel develops therapeutics for multiple diseases of aging including osteoarthritis, kidney disease, cardiovascular disease, skin aging, and complications of diabetes. It is commercializing therapeutic enzymes to degrade age-associated molecule damage. It was founded in 2019 and is based in San Francisco, California.
Revel Pharmaceuticals has raised $8.5M across 2 funding rounds on record, the most recent an undisclosed round of $80k announced in Oct 2025.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Revel Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Revel Pharmaceuticals Funding Rounds
Revel Pharmaceuticals raised $8.4M in a Seed announced in Mar 2022.
3.6 years later, an undisclosed round of $80k was announced in Oct 2025.
Revel Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Revel Pharmaceuticals Funding Compared to Other Biotechnology Startups
Revel Pharmaceuticals' latest round of $80k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Revel Pharmaceuticals in Biotechnology and San Francisco
Companies Similar to Revel Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Revel Pharmaceuticals Funding FAQs
What does Revel Pharmaceuticals do?
Revel develops therapeutics for multiple diseases of aging including osteoarthritis, kidney disease, cardiovascular disease, skin aging, and complications of diabetes. It is commercializing therapeutic enzymes to degrade age-associated molecule damage. It was founded in 2019 and is based in San Francisco, California.
How much funding has Revel Pharmaceuticals raised?
Revel Pharmaceuticals has raised $8.5M across 2 rounds on record. The most recent is an undisclosed round of $80k announced in Oct 2025.
When did Revel Pharmaceuticals last raise funding?
Revel Pharmaceuticals' most recent funding round on record is an undisclosed round of $80k, announced in Oct 2025.
Who is the CEO of Revel Pharmaceuticals?
Aaron Cravens is listed as CEO at Revel Pharmaceuticals.
Where is Revel Pharmaceuticals headquartered?
Revel Pharmaceuticals is based in San Francisco, California, United States.
How many employees does Revel Pharmaceuticals have?
Revel Pharmaceuticals is in the 1-10 employee band.
How does Revel Pharmaceuticals' funding compare to other Biotechnology startups?
Revel Pharmaceuticals' latest round of $80k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Revel Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Revel Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.